Home About Us Product BPH Overview Opportunity Contact Us  


There are approximately 30 million men worldwide experience moderate to severe BPH symptoms. Of this number, an estimated 25% require active treatment require active treatment (whether invasive or not). The symptoms of nearly half the BPH patients in the U.S. are severe enough to disrupt patients’ lifestyle and result in seeking treatment. This presents a significant unmet need for minimally invasive or less invasive BPH therapy as a less costly, more tolerable, and comparatively safe and effective alternative to drugs and invasive surgery, which carry greater risk of undesirable or significant side effects and complications1.

ClearRing is positioned to be the treatment of choice for patients who have unsuccessfully tried drugs and wish to avoid surgery.

1 MedTech Insight, 2011 report

  Home | About Us | Products | Opportunity | Contact Us